Amaria, R. N., Diab, A., Tawbi, H. A., Glitza, I. C., McQuade, J. L., Davies, M. A., Ikeguchi, A., Wong, M. K., Patel, S. P., Bassett, R. L., Jose, S., Lee, S., Isgandarova, S., Lu, H., Ramsingh, G., Renard, C., Burga, R. A., Aksoy, B. A., Haymaker, C. L. (2025). OBX-115 engineered tumor-infiltrating lymphocytes (TIL) with regulatable membrane-bound IL15 (mbIL15): Translational data from a single-center phase 1 trial in patients (pts) with immune checkpoint inhibitor (ICI)–resistant advanced melanoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.9519